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Derivative (y)t(Y;l)(ql2;ql2),+9 in a Patient with 
Polycythemia Vera During Transition 
into Myelodysplasia
R. Raymakers, F. Stellink, and A. Geurts van Kessel
ABSTRACT: Cytogenetic analysis of bone marrow cells of a 63-year-old male Caucasian patient with 
polycythemia vera [PV) who developed anemia, thrombocytopenia, and increased granulocytic imma­
turity revealed a 47,X,der(Y) t(Y;l)(ql2;ql2),+9 karyotype. The breakpoint in chromosome 1 appeared 
to map to q l2  and not to q21, as has been described in previous reports without FISH confirmation. In 
the 4 years before this transition the patient was polycythemic and, accordingly; treated with phlebot­
omy and three short courses of busulfan, The cytogenetic picture observed has been described before in 
seven patients: three with PV, three with myelodysplasia, and one with Fan coni anemia. In 5/7 cases, 
like in our patient, the abnormality was observed during transition of the disease into either myelodys­
plasia or AML.
INTRODUCTION
Several cytogenetic abnormalities have been described in 
patients with polycythemia vera (PV), These abnormalities 
are nonrandom, w ith  a most frequent involvement of chro­
mosomes 1 , 8 , 9, and 20 [1 ], Kaiyotypic changes may cor­
relate with transition of the disease, In this report a case 
history of a patient with PV is described. The karyotypic 
abnormalities found during transition of the disease into 
myelodysplasia correspond exactly with those described 
previously in three patients with PV, three with myelodys­
plasia (MDS), and one patient with Fanconi anemia (2-7).
CASE HISTORY
A Caucasian man, aged 63, presented with anorexia 
(weight loss of 7 kg), night sweats, cold feet and fingers, 
and erythema on his legs and feet, Five years before, erysi­
pelas on his right leg was diagnosed; 3 years later erysi­
pelas was seen on both legs. He had stopped smoking 
many years before. Laboratory examinations showed a 
hemoglobulin of 12.9 mmol/L, a hematocrit of 0.62 I/L,
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with a low mean cellular volume of 76 £L There was a leu­
kocytosis of 17,7 X lO^/L, w ith  81% neutrophils, 11% 
lymphocytes, and a normal thrombocyte count. The 
spleen was palpable just below the costal margin, A bone 
marrow aspirate showed a hypercellular marrow with 
megaloblastic erythropoiesis. He was diagnosed to have 
primary polycythemia and treated w ith  phlebotomy and 
acetosal. In the following years the patient frequently com ­
plained of bone pains. A bone scintigram showed increased 
activity in the femora and humeri.
Three years after diagnosis he was referred to our hos­
pital for a second opinion. He had complaints of pain in 
his legs while walking; standing upright was especially 
painful. In winter, his feet and fingers were cold. Physical 
examination showed areas w ith erythema and noduli on 
both upper arms and upper legs, w ith  pitting edema on his 
lower legs. His spleen was palpable 1 cm below the left 
costal margin. The hemoglobin content was 9,1 mmol/L, 
hematocrit 0*511/L, mean cellular volume 69 fi, leukocytes 
27 X 107L, and thrombocytes 231 X 10iJ/L. Hydroxycobal- 
amin levels were very high, 1 2 0 0  prnol/L. Leukocyte alka­
line phosphatase staining of the leukocytes was increased. 
Bone marrow smears revealed a normo cellular marrow 
with active hematopoiesis, 1 % myeloblasts, and 28% nor­
moblasts. Progenitor cell culture showed hyperplastic and 
spontaneous growth of CFU-GM and BFUe. A biopsy of 
the skin lesions was classified as a leukocytoclastic vascu­
litis, The patient was treated w ith  busulfan for 4 weeks, 4 
mg/day, 3 months later for another 2 weeks, 4 mg/day, and
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Figure 1 K aryotype of a patient-derived bone marrow cell, The translocation derivative chrom osom e der(Y) is 
m arked  by an arrow.
I
3 months later for a th ird  period of busulfan, 4 weeks, 4 
mg/day. After the acetosal was stopped and the poly­
cythemia treated effectively, the pain and skin lesions 
gradually disappeared. Four years after diagnosis anemia 
and thrombocytopenia developed, while the leukocyte 
count moved into the normal range. The patient became 
erythrocyte transfusion dependent.
Laboratory examinations revealed an increased LDH 
(473 U/L), while the haptoglobin was not decreased (2.01  
g/L). In the blood smear one blast-like cell, one promyelo­
cyte, and several rods were seen, but no normoblasts. 
Bone marrow aspirate smears showed an active and dys- 
plastic myelopoiesis w ith  no increase in blasts. A bone 
marrow biopsy showed a hypercellular marrow with pre­
dominant myelopoiesis w ith a left shift. The erythropoie- 
sis was megaloblastic and strongly suppressed. Cytogen­
etic analysis, performed according to standard methods 
[8 ], revealed a 47,X,der(Y)lt(Y;l)(ql2;ql2),+9 karyotype 
(Fig. 1 ). A whole chromosome paint (pBSl) and chromo­
some Y and 1 heterochromatin-specific probes (DYZl and 
PUC1.77) were used to confirm the translocation, as 
reported before [8 ], The der(Y) chromosome was positive 
for both DYZl and PUCl.77, thereby confirming the local­
ization of the breakpoints w ithin  the corresponding het- 
erochromatic regions of both chromosomes (data not 
shown].
At present, 1 year after the patient developed anemia, 
the clinical and laboratory situation is more or less stable.
He is erythrocyte transfusion dependent, requiring 2 units 
of packed cells/ week. The leukocytes remain stable 
between 8-12 X 10fl/L, with myelocytes and rods, bu t no 
blasts. The thrombocyte counts vary between 60 and 90 X
107L.
In summary, a patient with polycythemia vera, treated 
with phlebotomy and three short courses of busulfan, pro­
gressed into myelodysplasia with depressed erythropoie- 
sis and thrombopoiesis. There was no increase of blasts, 
During the phase of transition, chromosomal analysis 
revealed a 47,X,der(Y)t(Y;l}(ql2;ql2), + 9 karyotype,
DISCUSSION
In reviewing the literature, we found seven more patients 
with the same chromosomal aberration as found in  our 
case. In 3/8 (including our patient) the patients were diag­
nosed with polycythemia vera. One special case history of 
a patient with Fanconi anemia was described [4], In this 
patient the transient appearance of a clone with the chro­
mosomal aberration was found, not correlating with a dis­
tinct phase of the disease. The other three patients all had 
myelodysplasia: one CMMol with no blasts (this patient 
was lost to follow-up [2 ]; one patient with an RAEB, who 
evolved into AML 4 months after diagnosis [3]; and a third 
patients with an RA who was known to have neutro- and 
thrombocytopenia as well as monocytosis for 14 years, 
and evolved into AML, FAB M 2 and died 2 months later
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[5 ]. Remarkably, the 47,X,der(Y)t(Y;l)(ql2;ql2),+9 aberra­
tion was found in nearly all cases during transition of the 
disease. In 3/4 polycythemia vera patients the aberration 
correlated with transition into myelodysplasia; in one 
patient no data on transition were provided [7], In 2/3 
MDS patients the disease evolved into AML [3, 5]. One 
patient w ith CMMol was lost to follow-up [2], Recently, 
correlations between specific secondary karyotypic abnor­
malities and previous (chemo)therapy regimens have been 
described [9]. FISH analysis revealed that the breakpoint 
in chromosome 1 maps in band q l 2 , thereby revising its 
previously reported location (q2 1 ). More cases with simi­
lar karyotypes and disease histories have to be evaluated 
to establish the relationship between treatment regimens 
and transition of polycythemia vera into myelodysplasia, 
as well as establish this chromosomal aberration as a 
marker for transition independent of previous therapy.
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